| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2A14 NPY2R NPY6R OR4K17 OR4K13 GPR32P1 GPR84 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 RXFP3 SSTR2 SSTR4 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 P2RY1 ADGRE3 OR52E1 ADGRE4P OR4C46 HRH1 MRGPRX2 GPR171 OR52K2 ADGRA3 CXCR2 OR2AG1 | 2.59e-18 | 884 | 115 | 33 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2A14 NPY2R NPY6R OR4K17 OR4K13 GPR32P1 DDR2 GPR84 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 RXFP3 SSTR2 SSTR4 OR2L13 OR13J1 CHRNA4 OR4K14 UNC5A OR51F2 OR2A12 NRXN1 NRXN2 P2RY1 PTPRN2 ADGRE3 OR52E1 ADGRE4P OR4C46 HRH1 MRGPRX2 GPR171 OR52K2 ADGRA3 CXCR2 OR2AG1 | 7.44e-18 | 1353 | 115 | 39 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 OR52E1 OR4C46 OR52K2 OR2AG1 | 5.06e-11 | 431 | 115 | 18 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 7.61e-08 | 133 | 115 | 9 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.18e-07 | 140 | 115 | 9 | GO:0001653 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 5.89e-07 | 53 | 115 | 6 | GO:0008188 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.18e-06 | 37 | 115 | 5 | GO:0042923 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 4.27e-05 | 162 | 115 | 7 | GO:0099106 | |
| GeneOntologyMolecularFunction | channel regulator activity | 6.72e-05 | 174 | 115 | 7 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 7.48e-05 | 177 | 115 | 7 | GO:0141108 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.32e-04 | 85 | 115 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | virus receptor activity | 1.32e-04 | 85 | 115 | 5 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.39e-04 | 86 | 115 | 5 | GO:0140272 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 1.43e-04 | 18 | 115 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 3.25e-04 | 5 | 115 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | peptide YY receptor activity | 3.25e-04 | 5 | 115 | 2 | GO:0001601 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 3.25e-04 | 5 | 115 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | somatostatin receptor activity | 3.25e-04 | 5 | 115 | 2 | GO:0004994 | |
| GeneOntologyMolecularFunction | cyclase activity | 3.45e-04 | 24 | 115 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 3.90e-04 | 25 | 115 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | CTPase activity | 4.86e-04 | 6 | 115 | 2 | GO:0043273 | |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 1.15e-03 | 9 | 115 | 2 | GO:0045134 | |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHA9 DSC2 CDHR3 PCDHA1 TTYH3 CDH20 MGP NRXN1 ADGRE3 PKD2 ADGRE4P CDH9 | 1.28e-03 | 749 | 115 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 1.75e-03 | 11 | 115 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 2.09e-03 | 12 | 115 | 2 | GO:0004382 | |
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 2.46e-03 | 13 | 115 | 2 | GO:0045028 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2A14 ADCY4 NPY2R NPY6R OR4K17 OR4K13 GPR32P1 LRRK2 GPR84 ZDHHC7 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 RXFP3 SSTR2 SSTR4 ADCY1 OR2L13 ADCY6 OR13J1 OR4K14 OR51F2 OR2A12 P2RY1 ADGRE3 OR52E1 ADGRE4P OR4C46 HRH1 MRGPRX2 GPR171 OR52K2 ADGRA3 CXCR2 OR2AG1 | 9.81e-17 | 1395 | 117 | 38 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 OR52E1 OR4C46 OR52K2 OR2AG1 | 4.20e-11 | 432 | 117 | 18 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 SCARB1 OR52E1 OR4C46 OR52K2 OR2AG1 | 1.23e-10 | 524 | 117 | 19 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 OR52E1 OR4C46 OR52K2 OR2AG1 | 1.39e-10 | 465 | 117 | 18 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 OR52E1 OR4C46 OR52K2 OR2AG1 | 2.75e-10 | 485 | 117 | 18 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 CD1D OR2A12 SCARB1 PKD2 OR52E1 OR4C46 OR52K2 OR2AG1 | 6.65e-10 | 722 | 117 | 21 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 OR52E1 OR4C46 OR52K2 OR2AG1 | 1.86e-09 | 547 | 117 | 18 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 OR52E1 OR4C46 OR52K2 OR2AG1 | 4.92e-09 | 582 | 117 | 18 | GO:0050906 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHA9 DSC2 NRCAM CDHR3 MCAM PCDHA1 CLDN6 AMIGO1 SLITRK2 CDH20 NRXN1 CDH9 | 2.23e-07 | 313 | 117 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 5.36e-07 | 124 | 117 | 8 | GO:0007218 | |
| GeneOntologyBiologicalProcess | sensory perception | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 CHRNA4 OR4K14 OR51F2 OR2A12 OR52E1 OR4C46 MRGPRX2 GPR171 OR52K2 OR2AG1 | 5.90e-07 | 1072 | 117 | 21 | GO:0007600 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | ADCY4 NPY2R SSTR2 SSTR4 ADCY1 ADCY6 P2RY1 ADGRE3 ADGRE4P GPR171 | 5.43e-06 | 286 | 117 | 10 | GO:0007188 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.15e-05 | 187 | 117 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 2.84e-05 | 11 | 117 | 3 | GO:0006171 | |
| GeneOntologyBiologicalProcess | UDP catabolic process | 9.54e-05 | 3 | 117 | 2 | GO:0006256 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside diphosphate catabolic process | 9.54e-05 | 3 | 117 | 2 | GO:0009140 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside diphosphate catabolic process | 9.54e-05 | 3 | 117 | 2 | GO:0009195 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.30e-04 | 86 | 117 | 5 | GO:0007193 | |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 1.36e-04 | 18 | 117 | 3 | GO:1904322 | |
| GeneOntologyBiologicalProcess | response to forskolin | 1.61e-04 | 19 | 117 | 3 | GO:1904321 | |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 1.90e-04 | 4 | 117 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 2.32e-04 | 53 | 117 | 4 | GO:0016339 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 2.90e-04 | 23 | 117 | 3 | GO:0009190 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | CFTR DDR2 MARCHF6 LRRK2 ZDHHC7 NRROS ADCY6 CHRNA4 AMIGO1 COLEC12 ADIPOR1 VKORC1 SCAP P2RY1 USO1 PKD2 HRH1 MRGPRX2 | 2.90e-04 | 1272 | 117 | 18 | GO:1901698 |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 3.15e-04 | 5 | 117 | 2 | GO:0097116 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | CFTR DDR2 LRRK2 ZDHHC7 ADCY6 CHRNA4 AMIGO1 COLEC12 ADIPOR1 P2RY1 USO1 PKD2 HRH1 | 3.43e-04 | 752 | 117 | 13 | GO:1901699 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 3.65e-04 | 387 | 117 | 9 | GO:0050807 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 3.74e-04 | 25 | 117 | 3 | GO:0046058 | |
| GeneOntologyBiologicalProcess | synapse assembly | 3.77e-04 | 308 | 117 | 8 | GO:0007416 | |
| GeneOntologyBiologicalProcess | cell junction assembly | DOCK1 NRCAM CDHR3 CLDN6 AMIGO1 SLITRK2 CDH20 NRXN1 NRXN2 CDH9 TPBG | 3.96e-04 | 569 | 117 | 11 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 4.23e-04 | 395 | 117 | 9 | GO:0050803 | |
| GeneOntologyBiologicalProcess | somatostatin receptor signaling pathway | 4.71e-04 | 6 | 117 | 2 | GO:0038169 | |
| GeneOntologyBiologicalProcess | somatostatin signaling pathway | 4.71e-04 | 6 | 117 | 2 | GO:0038170 | |
| GeneOntologyBiologicalProcess | vocal learning | 6.58e-04 | 7 | 117 | 2 | GO:0042297 | |
| GeneOntologyBiologicalProcess | UDP metabolic process | 6.58e-04 | 7 | 117 | 2 | GO:0046048 | |
| GeneOntologyBiologicalProcess | imitative learning | 6.58e-04 | 7 | 117 | 2 | GO:0098596 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside diphosphate metabolic process | 6.58e-04 | 7 | 117 | 2 | GO:0009193 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 6.59e-04 | 185 | 117 | 6 | GO:0099175 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | CFTR LRRK2 ZDHHC7 SSTR2 SSTR4 ADCY1 ADCY6 COLEC12 P2RY1 PKD2 HRH1 | 6.60e-04 | 605 | 117 | 11 | GO:0071407 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 7.79e-04 | 191 | 117 | 6 | GO:0007189 | |
| GeneOntologyCellularComponent | cell surface | NRCAM CFTR MCAM LAMP1 NRROS CHRNA4 HAVCR1 CD1D CD8A CEACAM21 NRXN1 P2RY1 ASGR2 ADGRE3 SCARB1 ADGRE4P CORIN MUC1 ADGRA3 TPBG CXCR2 | 9.81e-07 | 1111 | 118 | 21 | GO:0009986 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | POMT2 PSEN2 MPDU1 CFTR CYP51A1 MARCHF6 LRRK2 ELOVL5 XK NRROS RETSAT CREB3L4 ZDHHC1 OR2L13 CD1D VKORC1 SCAP TMEM106C CTAGE1 PKD2 LMBRD1 ALG12 | 2.96e-06 | 1293 | 118 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | POMT2 PSEN2 MPDU1 CFTR CYP51A1 MARCHF6 LRRK2 ELOVL5 XK NRROS RETSAT CREB3L4 ZDHHC1 OR2L13 CD1D VKORC1 SCAP TMEM106C CTAGE1 PKD2 LMBRD1 ALG12 | 3.19e-06 | 1299 | 118 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | POMT2 PSEN2 MPDU1 CFTR CYP51A1 MARCHF6 LRRK2 ELOVL5 XK NRROS RETSAT CREB3L4 ZDHHC1 OR2L13 CD1D VKORC1 SCAP TMEM106C CTAGE1 PKD2 LMBRD1 ALG12 | 4.50e-06 | 1327 | 118 | 22 | GO:0042175 |
| GeneOntologyCellularComponent | lysosomal membrane | ACP2 CFTR LAMP1 CYB561A3 SLC7A14 ENTPD4 CD1D SCARB1 MFSD1 LMBRD1 | 2.93e-04 | 462 | 118 | 10 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | ACP2 CFTR LAMP1 CYB561A3 SLC7A14 ENTPD4 CD1D SCARB1 MFSD1 LMBRD1 | 2.93e-04 | 462 | 118 | 10 | GO:0098852 |
| GeneOntologyCellularComponent | side of membrane | NRCAM LRRK2 MCAM LAMP1 CHRNA4 CD1D CD8A CEACAM21 DPEP2 ASGR2 PKD2 ALG12 ADGRA3 CXCR2 | 4.19e-04 | 875 | 118 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | somatodendritic compartment | ADCY4 PSEN2 CFTR LRRK2 ELOVL5 TMEM185A LAMP1 CHRNA4 AMIGO1 UNC5A SLITRK2 NRXN1 P2RY1 HRH1 MRGPRX2 CDH9 TPBG | 5.30e-04 | 1228 | 118 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | vacuolar membrane | ACP2 CFTR LAMP1 CYB561A3 SLC7A14 ENTPD4 CD1D SCARB1 MFSD1 LMBRD1 | 6.06e-04 | 507 | 118 | 10 | GO:0005774 |
| GeneOntologyCellularComponent | external side of plasma membrane | NRCAM MCAM LAMP1 CHRNA4 CD1D CD8A CEACAM21 ASGR2 ADGRA3 CXCR2 | 7.25e-04 | 519 | 118 | 10 | GO:0009897 |
| GeneOntologyCellularComponent | catenin complex | 7.72e-04 | 32 | 118 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ENTPD7 CFTR LRRK2 LAIR1 GPR84 LAMP1 CYB561A3 ZDHHC1 COLEC12 CD1D SCAP PTPRN2 USO1 ADGRE3 SCARB1 PKD2 CXCR2 | 1.06e-03 | 1307 | 118 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | dendrite | ADCY4 CFTR LRRK2 ELOVL5 TMEM185A LAMP1 CHRNA4 AMIGO1 SLITRK2 P2RY1 HRH1 CDH9 TPBG | 1.12e-03 | 858 | 118 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ADCY4 CFTR LRRK2 ELOVL5 TMEM185A LAMP1 CHRNA4 AMIGO1 SLITRK2 P2RY1 HRH1 CDH9 TPBG | 1.14e-03 | 860 | 118 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | vesicle membrane | ENTPD7 CFTR LRRK2 LAIR1 GPR84 LAMP1 CYB561A3 ZDHHC1 COLEC12 CD1D SCAP PTPRN2 USO1 ADGRE3 SCARB1 PKD2 CXCR2 | 1.23e-03 | 1325 | 118 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | endocytic vesicle | 1.52e-03 | 384 | 118 | 8 | GO:0030139 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 1.84e-03 | 43 | 118 | 3 | GO:0032809 | |
| GeneOntologyCellularComponent | lysosome | ACP2 CFTR LRRK2 LAMP1 CYB561A3 SLC7A14 ENTPD4 CD1D SCARB1 MFSD1 LMBRD1 CXCR2 | 2.12e-03 | 811 | 118 | 12 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | ACP2 CFTR LRRK2 LAMP1 CYB561A3 SLC7A14 ENTPD4 CD1D SCARB1 MFSD1 LMBRD1 CXCR2 | 2.12e-03 | 811 | 118 | 12 | GO:0000323 |
| GeneOntologyCellularComponent | cell body membrane | 2.37e-03 | 47 | 118 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | tertiary granule | 2.40e-03 | 164 | 118 | 5 | GO:0070820 | |
| GeneOntologyCellularComponent | presynapse | PSEN2 CDHR3 LRRK2 LAMP1 ADCY1 CHRNA4 NRXN1 NRXN2 P2RY1 PTPRN2 CDH9 TPBG | 4.34e-03 | 886 | 118 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | autolysosome | 4.56e-03 | 18 | 118 | 2 | GO:0044754 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.91e-03 | 277 | 118 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 4.97e-03 | 61 | 118 | 3 | GO:0101003 | |
| GeneOntologyCellularComponent | microvillus | 5.23e-03 | 123 | 118 | 4 | GO:0005902 | |
| GeneOntologyCellularComponent | vacuole | ACP2 CFTR LRRK2 LAMP1 CYB561A3 SLC7A14 ENTPD4 CD1D SCARB1 MFSD1 LMBRD1 CXCR2 | 5.49e-03 | 913 | 118 | 12 | GO:0005773 |
| GeneOntologyCellularComponent | synaptic membrane | 5.83e-03 | 583 | 118 | 9 | GO:0097060 | |
| Domain | GPCR_Rhodpsn_7TM | OR2A14 NPY2R OR4K17 OR4K13 GPR84 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 RXFP3 SSTR2 SSTR4 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 P2RY1 OR4C46 HRH1 MRGPRX2 GPR171 OR52K2 CXCR2 OR2AG1 | 1.63e-15 | 670 | 111 | 27 | IPR017452 |
| Domain | 7tm_1 | OR2A14 NPY2R OR4K17 OR4K13 GPR84 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 RXFP3 SSTR2 SSTR4 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 P2RY1 OR4C46 HRH1 MRGPRX2 GPR171 OR52K2 CXCR2 OR2AG1 | 2.10e-15 | 677 | 111 | 27 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2A14 NPY2R OR4K17 OR4K13 GPR84 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 RXFP3 SSTR2 SSTR4 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 P2RY1 OR4C46 HRH1 MRGPRX2 GPR171 OR52K2 CXCR2 OR2AG1 | 2.80e-15 | 685 | 111 | 27 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2A14 NPY2R OR4K17 OR4K13 GPR84 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 RXFP3 SSTR2 SSTR4 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 P2RY1 OR4C46 HRH1 MRGPRX2 GPR171 OR52K2 CXCR2 OR2AG1 | 3.46e-15 | 691 | 111 | 27 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2A14 NPY2R OR4K17 OR4K13 GPR84 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 RXFP3 SSTR2 SSTR4 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 P2RY1 OR4C46 HRH1 MRGPRX2 GPR171 OR52K2 CXCR2 OR2AG1 | 3.59e-15 | 692 | 111 | 27 | IPR000276 |
| Domain | Olfact_rcpt | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 OR4C46 OR52K2 OR2AG1 | 1.65e-10 | 393 | 111 | 17 | IPR000725 |
| Domain | AC_N | 1.12e-05 | 8 | 111 | 3 | IPR032628 | |
| Domain | Adcy | 1.12e-05 | 8 | 111 | 3 | IPR030672 | |
| Domain | AC_N | 1.12e-05 | 8 | 111 | 3 | PF16214 | |
| Domain | IG_LIKE | NRCAM LAIR1 MCAM SEMA4G AMIGO1 UNC5A HAVCR1 CD1D CD8A CEACAM21 SIGLEC10 ADGRA3 | 3.55e-05 | 491 | 111 | 12 | PS50835 |
| Domain | IG | NRCAM LAIR1 MCAM SEMA4G AMIGO1 UNC5A HAVCR1 CD8A CEACAM21 SIGLEC10 ADGRA3 | 4.20e-05 | 421 | 111 | 11 | SM00409 |
| Domain | Ig_sub | NRCAM LAIR1 MCAM SEMA4G AMIGO1 UNC5A HAVCR1 CD8A CEACAM21 SIGLEC10 ADGRA3 | 4.20e-05 | 421 | 111 | 11 | IPR003599 |
| Domain | Ig-like_dom | NRCAM LAIR1 MCAM SEMA4G AMIGO1 UNC5A HAVCR1 CD1D CD8A CEACAM21 SIGLEC10 ADGRA3 | 4.49e-05 | 503 | 111 | 12 | IPR007110 |
| Domain | CADHERIN_1 | 5.80e-05 | 113 | 111 | 6 | PS00232 | |
| Domain | Cadherin | 5.80e-05 | 113 | 111 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 6.09e-05 | 114 | 111 | 6 | PS50268 | |
| Domain | - | 6.09e-05 | 114 | 111 | 6 | 2.60.40.60 | |
| Domain | CA | 6.40e-05 | 115 | 111 | 6 | SM00112 | |
| Domain | Cadherin-like | 6.71e-05 | 116 | 111 | 6 | IPR015919 | |
| Domain | Cadherin | 7.39e-05 | 118 | 111 | 6 | IPR002126 | |
| Domain | GPCR_2_EMR1-like_rcpt | 1.05e-04 | 3 | 111 | 2 | IPR001740 | |
| Domain | A/G_cyclase_CS | 1.31e-04 | 17 | 111 | 3 | IPR018297 | |
| Domain | Nucleotide_cyclase | 1.56e-04 | 18 | 111 | 3 | IPR029787 | |
| Domain | - | 1.56e-04 | 18 | 111 | 3 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 1.85e-04 | 19 | 111 | 3 | PS00452 | |
| Domain | Guanylate_cyc | 1.85e-04 | 19 | 111 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 1.85e-04 | 19 | 111 | 3 | PS50125 | |
| Domain | A/G_cyclase | 1.85e-04 | 19 | 111 | 3 | IPR001054 | |
| Domain | CYCc | 1.85e-04 | 19 | 111 | 3 | SM00044 | |
| Domain | Somatstn_rcpt | 3.46e-04 | 5 | 111 | 2 | IPR000586 | |
| Domain | Cadherin_cytoplasmic-dom | 4.27e-04 | 25 | 111 | 3 | IPR000233 | |
| Domain | Cadherin_C | 4.27e-04 | 25 | 111 | 3 | PF01049 | |
| Domain | Cadherin_CS | 4.84e-04 | 109 | 111 | 5 | IPR020894 | |
| Domain | Adcy_conserved_dom | 5.17e-04 | 6 | 111 | 2 | IPR009398 | |
| Domain | DUF1053 | 5.17e-04 | 6 | 111 | 2 | PF06327 | |
| Domain | LRR_8 | 5.53e-04 | 171 | 111 | 6 | PF13855 | |
| Domain | - | NRCAM LAIR1 MCAM SEMA4G AMIGO1 UNC5A HAVCR1 CD1D CD8A CEACAM21 SIGLEC10 ADGRA3 | 5.78e-04 | 663 | 111 | 12 | 2.60.40.10 |
| Domain | Leu-rich_rpt_typical-subtyp | 6.62e-04 | 177 | 111 | 6 | IPR003591 | |
| Domain | LRR_TYP | 6.62e-04 | 177 | 111 | 6 | SM00369 | |
| Domain | Catenin_binding_dom | 6.67e-04 | 29 | 111 | 3 | IPR027397 | |
| Domain | - | 6.67e-04 | 29 | 111 | 3 | 4.10.900.10 | |
| Domain | Syndecan | 7.21e-04 | 7 | 111 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 7.21e-04 | 7 | 111 | 2 | IPR027789 | |
| Domain | V-set | 8.11e-04 | 184 | 111 | 6 | PF07686 | |
| Domain | GDA1_CD39_NTPase | 9.57e-04 | 8 | 111 | 2 | IPR000407 | |
| Domain | GDA1_CD39 | 9.57e-04 | 8 | 111 | 2 | PF01150 | |
| Domain | GDA1_CD39_NTPASE | 9.57e-04 | 8 | 111 | 2 | PS01238 | |
| Domain | Ig_I-set | 9.58e-04 | 190 | 111 | 6 | IPR013098 | |
| Domain | ig | 9.58e-04 | 190 | 111 | 6 | PF00047 | |
| Domain | Immunoglobulin | 9.58e-04 | 190 | 111 | 6 | IPR013151 | |
| Domain | I-set | 9.58e-04 | 190 | 111 | 6 | PF07679 | |
| Domain | Ig-like_fold | NRCAM LAIR1 MCAM SEMA4G AMIGO1 UNC5A HAVCR1 CD1D CD8A CEACAM21 SIGLEC10 ADGRA3 | 1.00e-03 | 706 | 111 | 12 | IPR013783 |
| Domain | GPS | 1.07e-03 | 34 | 111 | 3 | SM00303 | |
| Domain | GPS | 1.16e-03 | 35 | 111 | 3 | PF01825 | |
| Domain | Ig_V-set | 1.22e-03 | 199 | 111 | 6 | IPR013106 | |
| Domain | GPS | 1.26e-03 | 36 | 111 | 3 | PS50221 | |
| Domain | LRR | 1.28e-03 | 201 | 111 | 6 | PS51450 | |
| Domain | GPS | 1.37e-03 | 37 | 111 | 3 | IPR000203 | |
| Domain | LRR_1 | 1.98e-03 | 219 | 111 | 6 | PF00560 | |
| Domain | Cys-rich_flank_reg_C | 2.04e-03 | 90 | 111 | 4 | IPR000483 | |
| Domain | LRRCT | 2.04e-03 | 90 | 111 | 4 | SM00082 | |
| Domain | Neurexin-like | 3.04e-03 | 14 | 111 | 2 | IPR003585 | |
| Domain | 4.1m | 3.04e-03 | 14 | 111 | 2 | SM00294 | |
| Domain | - | 3.07e-03 | 321 | 111 | 7 | 3.80.10.10 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 3.27e-03 | 50 | 111 | 3 | PS00650 | |
| Domain | 7tm_2 | 3.27e-03 | 50 | 111 | 3 | PF00002 | |
| Domain | L_dom-like | 3.46e-03 | 328 | 111 | 7 | IPR032675 | |
| Domain | 7TM_GPCR_Srsx | 4.49e-03 | 112 | 111 | 4 | SM01381 | |
| Domain | Ig/MHC_CS | 4.97e-03 | 58 | 111 | 3 | IPR003006 | |
| Domain | GPCR_2_secretin-like | 5.47e-03 | 60 | 111 | 3 | IPR000832 | |
| Domain | IG_MHC | 5.47e-03 | 60 | 111 | 3 | PS00290 | |
| Domain | Leu-rich_rpt | 5.62e-03 | 271 | 111 | 6 | IPR001611 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 5.72e-03 | 61 | 111 | 3 | PS50261 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 OR52E1 OR4C46 OR52K2 OR2AG1 | 1.98e-10 | 417 | 93 | 18 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR2A14 OR4K17 OR4K13 OR5T2 OR14I1 OR2B3 OR2A5 OR2T12 OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 OR4C46 OR52K2 OR2AG1 | 4.55e-09 | 389 | 93 | 16 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR2A14 OR4K17 OR4K13 OR5T2 OR5H15 OR14I1 OR2B3 OR2A5 OR2T12 RETSAT OR2L13 OR13J1 OR4K14 OR51F2 OR2A12 OR52E1 OR4C46 OR52K2 OR2AG1 | 2.60e-08 | 636 | 93 | 19 | M41834 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.70e-06 | 186 | 93 | 9 | MM15994 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | NPY2R NPY6R OR2B3 SSTR2 SSTR4 P2RY1 HRH1 GPR171 CXCR2 OR2AG1 | 8.07e-06 | 260 | 93 | 10 | M39397 |
| Pathway | WP_GPCRS_NONODORANT | NPY2R NPY6R RXFP3 SSTR2 SSTR4 P2RY1 ADGRE3 ADGRE4P HRH1 CXCR2 | 9.85e-06 | 266 | 93 | 10 | MM15843 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.70e-05 | 24 | 93 | 4 | M47520 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.37e-05 | 26 | 93 | 4 | M47553 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.77e-05 | 27 | 93 | 4 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.77e-05 | 27 | 93 | 4 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 3.22e-05 | 28 | 93 | 4 | M47647 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 3.23e-05 | 10 | 93 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 3.23e-05 | 10 | 93 | 3 | MM14668 | |
| Pathway | WP_GPCRS_OTHER | 3.37e-05 | 93 | 93 | 6 | M39629 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 3.72e-05 | 29 | 93 | 4 | M47515 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 3.72e-05 | 29 | 93 | 4 | M47627 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 4.87e-05 | 31 | 93 | 4 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 5.54e-05 | 32 | 93 | 4 | M47506 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 9.60e-05 | 14 | 93 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 9.60e-05 | 14 | 93 | 3 | M750 | |
| Pathway | WP_GPCRS_PEPTIDE | 9.68e-05 | 70 | 93 | 5 | MM15959 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.19e-04 | 15 | 93 | 3 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 1.19e-04 | 15 | 93 | 3 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 1.19e-04 | 15 | 93 | 3 | M47504 | |
| Pathway | WP_PEPTIDE_GPCRS | 1.34e-04 | 75 | 93 | 5 | M39696 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 1.46e-04 | 16 | 93 | 3 | M39849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 1.46e-04 | 16 | 93 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 1.46e-04 | 16 | 93 | 3 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.46e-04 | 16 | 93 | 3 | MM14492 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 1.77e-04 | 17 | 93 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.77e-04 | 17 | 93 | 3 | M47544 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.92e-04 | 20 | 93 | 3 | M759 | |
| Pathway | WP_GPCRS_ODORANT | 5.95e-04 | 157 | 93 | 6 | MM15872 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 6.39e-04 | 289 | 93 | 8 | MM15057 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 6.47e-04 | 26 | 93 | 3 | MM14495 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | ADCY4 NPY2R GPR84 XK RXFP3 SSTR2 SSTR4 ADCY1 ADCY6 P2RY1 ADGRE3 HRH1 CXCR2 | 6.78e-04 | 702 | 93 | 13 | M746 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | ADCY4 NPY2R GPR84 XK RXFP3 SSTR2 SSTR4 ADCY1 ADCY6 P2RY1 HRH1 CXCR2 | 1.08e-03 | 646 | 93 | 12 | MM14962 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.09e-03 | 314 | 93 | 8 | M600 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 1.17e-03 | 8 | 93 | 2 | M27737 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 1.17e-03 | 8 | 93 | 2 | MM15486 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 1.31e-03 | 33 | 93 | 3 | MM15058 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 1.31e-03 | 33 | 93 | 3 | M11575 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.50e-03 | 330 | 93 | 8 | M18334 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.56e-03 | 35 | 93 | 3 | M47969 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.59e-03 | 333 | 93 | 8 | MM14963 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.84e-03 | 37 | 93 | 3 | M749 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.86e-03 | 133 | 93 | 5 | M16476 | |
| Pathway | BIOCARTA_CFTR_PATHWAY | 1.87e-03 | 10 | 93 | 2 | MM1377 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.92e-03 | 197 | 93 | 6 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.92e-03 | 197 | 93 | 6 | MM14970 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.14e-03 | 39 | 93 | 3 | MM14496 | |
| Pathway | BIOCARTA_CFTR_PATHWAY | 2.28e-03 | 11 | 93 | 2 | M12399 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 2.39e-03 | 85 | 93 | 4 | M48315 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.47e-03 | 41 | 93 | 3 | M512 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 2.83e-03 | 43 | 93 | 3 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 2.83e-03 | 43 | 93 | 3 | M933 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.83e-03 | 43 | 93 | 3 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 3.03e-03 | 44 | 93 | 3 | MM15709 | |
| Pathway | REACTOME_GPER1_SIGNALING | 3.23e-03 | 45 | 93 | 3 | M45008 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 3.44e-03 | 46 | 93 | 3 | M39828 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 3.45e-03 | 463 | 93 | 9 | M507 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 3.88e-03 | 48 | 93 | 3 | M10775 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 4.28e-03 | 15 | 93 | 2 | MM14965 | |
| Pathway | KEGG_MELANOGENESIS | 4.45e-03 | 101 | 93 | 4 | M7761 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR2A14 OR5T2 OR5H15 OR2A5 OR2T12 OR2L13 OR13J1 OR51F2 OR2A12 OR4C46 OR52K2 OR2AG1 | 2.12e-09 | 340 | 118 | 12 | 11875048 |
| Pubmed | OR2A14 OR5T2 OR5H15 OR2A5 OR2T12 OR2L13 OR13J1 OR51F2 OR2A12 OR4C46 OR52K2 OR2AG1 | 2.12e-09 | 340 | 118 | 12 | 11802173 | |
| Pubmed | OR2A14 OR5T2 OR5H15 OR2A5 OR2T12 OR2L13 OR13J1 OR51F2 OR2A12 OR4C46 OR52K2 OR2AG1 | 2.34e-09 | 343 | 118 | 12 | 32295537 | |
| Pubmed | OR2A14 OR5T2 OR5H15 OR2A5 OR2T12 OR2L13 OR13J1 OR51F2 OR2A12 OR4C46 OR52K2 OR2AG1 | 2.58e-09 | 346 | 118 | 12 | 14611657 | |
| Pubmed | OR2A14 OR4K17 OR4K13 OR5T2 OR2B3 OR2T12 OR13J1 OR4K14 OR51F2 OR2A12 OR52K2 OR2AG1 | 3.40e-07 | 541 | 118 | 12 | 14983052 | |
| Pubmed | Mammalian adenylyl cyclase family members are randomly located on different chromosomes. | 3.79e-07 | 5 | 118 | 3 | 7959689 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | PSEN2 ACP2 ELOVL5 TTYH3 ENTPD4 ADCY6 HAVCR1 ADIPOR1 SCAP TMEM168 USO1 TMEM106C SCARB1 MMP15 ADGRA3 TPBG | 6.37e-07 | 1061 | 118 | 16 | 33845483 |
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 7.56e-07 | 6 | 118 | 3 | 7766992 | |
| Pubmed | Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. | 7.56e-07 | 6 | 118 | 3 | 11549699 | |
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 9.44e-07 | 52 | 118 | 5 | 24613359 | |
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 12613887 | ||
| Pubmed | Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins. | 1.51e-06 | 25 | 118 | 4 | 28154160 | |
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 3.15e-06 | 9 | 118 | 3 | 9417641 | |
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 3.15e-06 | 9 | 118 | 3 | 17229090 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ENTPD7 POMT2 NEMP1 DNAJB11 CYP51A1 MARCHF6 ELOVL5 MCAM LAMP1 SCAP TMEM106C SLC5A6 SCARB1 PKD2 ALG12 ADGRA3 | 3.16e-06 | 1201 | 118 | 16 | 35696571 |
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 4.49e-06 | 10 | 118 | 3 | 11884542 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 4.49e-06 | 10 | 118 | 3 | 8663304 | |
| Pubmed | 4.49e-06 | 10 | 118 | 3 | 16615126 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | LAIR1 SSTR4 HAVCR1 COLEC12 CD1D SLITRK2 CD8A ASGR2 ADGRE3 SIGLEC10 HRH1 MUC1 CXCR2 | 4.77e-06 | 824 | 118 | 13 | 20237496 |
| Pubmed | 6.16e-06 | 11 | 118 | 3 | 10089566 | ||
| Pubmed | 6.16e-06 | 11 | 118 | 3 | 10808179 | ||
| Pubmed | 6.16e-06 | 11 | 118 | 3 | 11299302 | ||
| Pubmed | 8.19e-06 | 12 | 118 | 3 | 10807185 | ||
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 1.04e-05 | 219 | 118 | 7 | 12213199 | |
| Pubmed | 1.05e-05 | 40 | 118 | 4 | 25275127 | ||
| Pubmed | Kidney injury molecule 1 (Kim1) is a novel ciliary molecule and interactor of polycystin 2. | 1.14e-05 | 2 | 118 | 2 | 18273441 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20070602 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 34151589 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 30709877 | ||
| Pubmed | CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation. | 1.14e-05 | 2 | 118 | 2 | 18199703 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20624691 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20554763 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 12210479 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26595880 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19623609 | ||
| Pubmed | Gene structure and transcript analysis of the human and mouse EGF-TM7 molecule, FIRE. | 1.14e-05 | 2 | 118 | 2 | 16753812 | |
| Pubmed | Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus. | 1.14e-05 | 2 | 118 | 2 | 9819365 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 11564768 | ||
| Pubmed | Association between polymorphisms in the P2RY1 and SSTR2 genes and sudden infant death syndrome. | 1.14e-05 | 2 | 118 | 2 | 23828624 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 35381269 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26040031 | ||
| Pubmed | Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality. | 1.14e-05 | 2 | 118 | 2 | 27986975 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 12372020 | ||
| Pubmed | CFTR and PC2, partners in the primary cilia in autosomal dominant polycystic kidney disease. | 1.14e-05 | 2 | 118 | 2 | 37519231 | |
| Pubmed | Overexpression of MUC1 predicts poor prognosis in patients with breast cancer. | 1.14e-05 | 2 | 118 | 2 | 30483806 | |
| Pubmed | Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. | 1.14e-05 | 2 | 118 | 2 | 1621094 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20220086 | ||
| Pubmed | Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice. | 1.14e-05 | 2 | 118 | 2 | 12529261 | |
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 1.35e-05 | 14 | 118 | 3 | 14993377 | |
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 1.68e-05 | 15 | 118 | 3 | 2165385 | |
| Pubmed | 2.06e-05 | 16 | 118 | 3 | 17567809 | ||
| Pubmed | MafB-dependent neurotransmitter signaling promotes β cell migration in the developing pancreas. | 2.50e-05 | 17 | 118 | 3 | 36897571 | |
| Pubmed | 2.50e-05 | 17 | 118 | 3 | 16472605 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 38891114 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 11472428 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 20404101 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 27826057 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 16406382 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 22572847 | ||
| Pubmed | Rhinovirus in the Pathogenesis and Clinical Course of Asthma. | 3.42e-05 | 3 | 118 | 2 | 26270739 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 31005376 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 11872746 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 10919985 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 29812984 | ||
| Pubmed | Somatostatin signaling in neuronal cilia is critical for object recognition memory. | 3.42e-05 | 3 | 118 | 2 | 20335466 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 3.42e-05 | 3 | 118 | 2 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 3.42e-05 | 3 | 118 | 2 | 11944992 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 3.42e-05 | 3 | 118 | 2 | 17035546 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 23061681 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 3.42e-05 | 3 | 118 | 2 | 25423136 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 3.42e-05 | 3 | 118 | 2 | 34133920 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 9892014 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 19567877 | ||
| Pubmed | Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. | 3.42e-05 | 3 | 118 | 2 | 21424692 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 30858964 | ||
| Pubmed | Somatostatin receptor subtype 4 couples to the M-current to regulate seizures. | 3.42e-05 | 3 | 118 | 2 | 18385315 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 28013231 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 31812984 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 3.42e-05 | 3 | 118 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 3.42e-05 | 3 | 118 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 3.42e-05 | 3 | 118 | 2 | 29045040 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 38571813 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 35173587 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 12709506 | ||
| Pubmed | Characterizing CEACAM5 interaction with CD8α and CD1d in intestinal homeostasis. | 3.42e-05 | 3 | 118 | 2 | 24104458 | |
| Pubmed | Effect of cortistatin on tau phosphorylation at Ser262 site. | 3.42e-05 | 3 | 118 | 2 | 18438934 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 12023293 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 3.42e-05 | 3 | 118 | 2 | 7722633 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 31904814 | ||
| Pubmed | 3.49e-05 | 179 | 118 | 6 | 18577758 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 32706374 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 17081159 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 8786425 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 17347997 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 21084199 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 10087204 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 35385735 | ||
| Interaction | CANX interactions | POMT2 NEMP1 DNAJB11 NRCAM ACP2 CFTR CYP51A1 LRRK2 ELOVL5 LAMP1 NRROS AMIGO1 COLEC12 CD1D SCAP NRXN1 TMEM106C SLC5A6 SCARB1 PKD2 LMBRD1 | 1.31e-06 | 1261 | 103 | 21 | int:CANX |
| Interaction | COX18 interactions | 7.13e-06 | 8 | 103 | 3 | int:COX18 | |
| Interaction | FBXO2 interactions | POMT2 DSC2 ACP2 MCAM SEMA4G COLEC12 SCAP SCARB1 PKD2 ADGRA3 TPBG | 8.24e-06 | 411 | 103 | 11 | int:FBXO2 |
| Interaction | CHRNB2 interactions | 1.47e-05 | 103 | 103 | 6 | int:CHRNB2 | |
| Interaction | PLPP6 interactions | 2.38e-05 | 67 | 103 | 5 | int:PLPP6 | |
| Interaction | PCDHA3 interactions | 2.65e-05 | 34 | 103 | 4 | int:PCDHA3 | |
| Interaction | C3orf52 interactions | 2.68e-05 | 305 | 103 | 9 | int:C3orf52 | |
| Interaction | CLGN interactions | 2.78e-05 | 235 | 103 | 8 | int:CLGN | |
| Interaction | IPPK interactions | 2.90e-05 | 116 | 103 | 6 | int:IPPK | |
| Interaction | TMEM59 interactions | 4.02e-05 | 181 | 103 | 7 | int:TMEM59 | |
| Interaction | CXCL9 interactions | 5.28e-05 | 79 | 103 | 5 | int:CXCL9 | |
| Interaction | ASIC4 interactions | 6.51e-05 | 134 | 103 | 6 | int:ASIC4 | |
| Interaction | SLC38A7 interactions | 8.85e-05 | 88 | 103 | 5 | int:SLC38A7 | |
| Interaction | TM4SF18 interactions | 9.69e-05 | 47 | 103 | 4 | int:TM4SF18 | |
| Interaction | LPAR1 interactions | 1.03e-04 | 210 | 103 | 7 | int:LPAR1 | |
| Interaction | ADCY9 interactions | 1.31e-04 | 152 | 103 | 6 | int:ADCY9 | |
| Interaction | SFTPC interactions | 1.45e-04 | 222 | 103 | 7 | int:SFTPC | |
| Interaction | TTYH1 interactions | 1.54e-04 | 300 | 103 | 8 | int:TTYH1 | |
| Interaction | CORT interactions | 1.61e-04 | 21 | 103 | 3 | int:CORT | |
| Interaction | HLA-DMB interactions | 2.06e-04 | 57 | 103 | 4 | int:HLA-DMB | |
| GeneFamily | Olfactory receptors, family 2 | 1.02e-06 | 113 | 85 | 7 | 149 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.18e-05 | 10 | 85 | 3 | 53 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.19e-04 | 163 | 85 | 6 | 590 | |
| GeneFamily | Somatostatin receptors | 2.16e-04 | 5 | 85 | 2 | 257 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 2.16e-04 | 5 | 85 | 2 | 915 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.28e-04 | 394 | 85 | 8 | 471 | |
| GeneFamily | Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis | 7.70e-04 | 9 | 85 | 2 | 430 | |
| GeneFamily | Neuropeptide receptors | 9.59e-04 | 10 | 85 | 2 | 854 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.65e-03 | 13 | 85 | 2 | 1186 | |
| GeneFamily | Immunoglobulin like domain containing | 2.16e-03 | 193 | 85 | 5 | 594 | |
| GeneFamily | Olfactory receptors, family 4 | 3.21e-03 | 129 | 85 | 4 | 151 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 5.64e-03 | 24 | 85 | 2 | 76 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 5.92e-03 | 78 | 85 | 3 | 262 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 7.10e-03 | 27 | 85 | 2 | 1253 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 4.90e-05 | 86 | 98 | 5 | GSM605840_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3 | 5.17e-05 | 87 | 98 | 5 | GSM854299_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2 | 5.17e-05 | 87 | 98 | 5 | GSM854297_100 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-08 | 192 | 118 | 8 | 90274b85f3d612b6a6d435860cd6d049ddeb1d96 | |
| ToppCell | severe_influenza-Non-classical_Monocyte|severe_influenza / disease group, cell group and cell class (v2) | 5.04e-08 | 194 | 118 | 8 | 7630e223666fb65743e21e045478f687dd739a54 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD16|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.38e-08 | 200 | 118 | 8 | 94d7aa057a31287696a634d15ce91ce64af6455b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.90e-07 | 172 | 118 | 7 | 422d311bba2dd5d8bece4e96ee8c86e78086b62d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.90e-07 | 172 | 118 | 7 | 1abb6fbb28c8aff384540493d0f70eeacaa751f4 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.61e-07 | 190 | 118 | 7 | b8c131020d20005cd9f23d26312196f62c958074 | |
| ToppCell | Influenza_Severe-Non-classical_Monocyte|Influenza_Severe / Disease group and Cell class | 7.88e-07 | 191 | 118 | 7 | 197edf6feb1cfc71d88e532d74f77305a42a3486 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.06e-07 | 195 | 118 | 7 | 6d60a364b8c5c3384a430b858435f5cc542d80e3 | |
| ToppCell | Influenza_Severe-Non-classical_Monocyte|World / Disease group and Cell class | 9.37e-07 | 196 | 118 | 7 | 8ef9810ee99082a9c803c7ecad6ceb5710d16b54 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.70e-07 | 197 | 118 | 7 | 780ab4a9f1dbf1f58b70a716ba2949c4f51b9295 | |
| ToppCell | severe_influenza-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.00e-06 | 198 | 118 | 7 | 790ee20abc9666b8095675b0d445c0914ee70ea3 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-06 | 199 | 118 | 7 | 4e0b73d88b1345ec63a9e5629762341e75beb47f | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.07e-06 | 200 | 118 | 7 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.07e-06 | 200 | 118 | 7 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.07e-06 | 200 | 118 | 7 | 5490393c5f54748f912676e19b58bd1320415a06 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.07e-06 | 200 | 118 | 7 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.07e-06 | 200 | 118 | 7 | df821ac12953e44fcfedbbefb35a4976e406ccd6 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-06 | 167 | 118 | 6 | 1bd0aa7a3c8649f342bb856cf861c4c5984ad889 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-06 | 170 | 118 | 6 | 749144a1a869a6bf9acdd227184319083367dc3f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-06 | 170 | 118 | 6 | 25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-06 | 172 | 118 | 6 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-06 | 172 | 118 | 6 | 1627fa7035b0e0bbc82a1c0f000d8231254c680a | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-06 | 179 | 118 | 6 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-06 | 179 | 118 | 6 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-06 | 183 | 118 | 6 | b5782b18decfe85026acf42daac0670d92385861 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-06 | 183 | 118 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-06 | 183 | 118 | 6 | e32847cfebba7c8bb2026e33c3c85f64819460a9 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-05 | 185 | 118 | 6 | 00a991e63e9ac6de3f48a96e3be6073f90cbb442 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Neutrophil|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.00e-05 | 185 | 118 | 6 | 655fb705d7a029844ecb4f6a53e948e37ee81006 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-05 | 186 | 118 | 6 | 69b107ad88b07e9aeef09d4e4dac99b0cb6b467e | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.03e-05 | 186 | 118 | 6 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.03e-05 | 186 | 118 | 6 | be50f5c7f32b3126442ebff1e7d38aa78b6e4e71 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.07e-05 | 187 | 118 | 6 | 88fac9f23047892acccbcc355d02ff079596fedf | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 188 | 118 | 6 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-05 | 190 | 118 | 6 | 0eef5a8bd88ef8a25a67d9dd522d9472fa4b3d2f | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 190 | 118 | 6 | 240923769fef18eaf73d2efa3d5f745f5533b0ce | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.17e-05 | 190 | 118 | 6 | 2724e8f375d8d9f5f2a77444e0491af264babac5 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.17e-05 | 190 | 118 | 6 | 11fbd4e9f02750354b3aadf30edc991f8d4f8f41 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-05 | 190 | 118 | 6 | 148d43dd72e2e22b2cd68e17fedae6bd98b32aee | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 190 | 118 | 6 | 9df9b9e91c97e504c189d6055a6aabc54ad17cec | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM1|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.20e-05 | 191 | 118 | 6 | bd641aab36276dd952a7265ee79ba455b38d8e6b | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 118 | 6 | 4187f31ec399b4c7c3608e94e3c32b7a54b1c3d4 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 118 | 6 | 8e8bc200524a44ebe132f823ab7c15dac65d4952 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 192 | 118 | 6 | b9d6cf6068ffa104968f4944cbf8af6faa2b8942 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-05 | 194 | 118 | 6 | e3688f4252aae5f849f025d7f453ff4c0c14590b | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 195 | 118 | 6 | f289a44010788853d7726d4b5aa75f3c62186c08 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 195 | 118 | 6 | 97a9410f47beca02346902d078288a75bfe6e56b | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 196 | 118 | 6 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 196 | 118 | 6 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.39e-05 | 196 | 118 | 6 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.39e-05 | 196 | 118 | 6 | f811958823380069077754283e36106d80147494 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.39e-05 | 196 | 118 | 6 | b2aee2f67da373a10b0c25e7797e30e3811543a8 | |
| ToppCell | Bronchial_Biopsy-Immune-Dendritic_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.39e-05 | 196 | 118 | 6 | bd828596c5b3fd5e4156f555e532f3de99d32f92 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.43e-05 | 197 | 118 | 6 | d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.43e-05 | 197 | 118 | 6 | 1a30747a2188a890f58d831030328986b3a4356d | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-05 | 197 | 118 | 6 | 33f2fe101ae5744eea3915add37e60aa398bb97f | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-05 | 197 | 118 | 6 | 5e9a3932ae5147a3d73dc70f1545926a692930ed | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.43e-05 | 197 | 118 | 6 | 8a126cfe1529f3d75a806aa492743314a8a43ef9 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.43e-05 | 197 | 118 | 6 | 9262785807faeb32417fad7ef202405053e453e2 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.47e-05 | 198 | 118 | 6 | 1d242fbe4ae3628103f6b6f910a7641bb1b75266 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 198 | 118 | 6 | 243109377d62d20c69e9d1fedc252156e90cda1e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 198 | 118 | 6 | 6a4161680b46b2c12353a693c403b5a4bb3da03f | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 198 | 118 | 6 | 115f564af8d7b89ac0331d3831faaef694043fd4 | |
| ToppCell | Healthy_donor-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.52e-05 | 199 | 118 | 6 | 45e9099a13becb1e235435ceaaffb92b82ce34ee | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 199 | 118 | 6 | 7648860058eec66019b574ad840d6f5cfa4476d9 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 199 | 118 | 6 | 91c72e06a7416671977430211c57938e39e8195e | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 199 | 118 | 6 | 368e2bafae00ce8e9c6ea480f81b78f96b680acd | |
| ToppCell | control-Myeloid-CD14_Monocytes_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.52e-05 | 199 | 118 | 6 | 8c14237c3da91d1a4878df489a495408a1e83883 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 118 | 6 | 1a080564de59abd59d3208a73441b6346e1c7cd8 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 118 | 6 | 4b4df0fe47498310d94448b8a289e58e4f5b5aa8 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-CD16+_Monocyte|Influenza_Severe / Disease, condition lineage and cell class | 1.56e-05 | 200 | 118 | 6 | 1efdcfcd86e99fbe03db19a2a5ab10808eec282d | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.56e-05 | 200 | 118 | 6 | 4758b96725699641b55a665533adf2d238032b09 | |
| ToppCell | mild-Myeloid-CD14_Monocytes_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.56e-05 | 200 | 118 | 6 | 3874c1f078cb8789be2e2275a202357c711b1be3 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-3|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 3.12e-05 | 136 | 118 | 5 | 4f5e0b6c7d6e3e922af4daa7c3eb56490455c1df | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.52e-05 | 78 | 118 | 4 | d5e2e2e04e380b265b2530e93cba6f98ad329e4f | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.00e-05 | 156 | 118 | 5 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 160 | 118 | 5 | 237430af14830b38e58da8a4224036e5c6b71c5b | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-05 | 160 | 118 | 5 | 5d22c86deead516444349d495998e04586be4396 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Mast|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-05 | 160 | 118 | 5 | ca212634cf1875238071d1800ecdf34979a553fb | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|tumor_Lung / Location, Cell class and cell subclass | 7.17e-05 | 162 | 118 | 5 | 9ac3242511315224ed94582aca9e9a3786cd01a0 | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-05 | 164 | 118 | 5 | d57faa4fce1f1e9a92aaf5cb920af99323252e4b | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-05 | 164 | 118 | 5 | d0b6c29e61d15f4dbe4c1f6e5ed3e10f41f820ab | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-05 | 164 | 118 | 5 | 718cc64b7ef7d03d095be4b2b54c449154da568c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-05 | 165 | 118 | 5 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-05 | 165 | 118 | 5 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-05 | 165 | 118 | 5 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | facs-MAT-Fat-18m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-05 | 166 | 118 | 5 | 9116be2805c34881debb999d8417e43832fcf2f2 | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-05 | 166 | 118 | 5 | 5c2667da79935f3d4b1edbfe7a10e7dbc2fa3ad0 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-05 | 167 | 118 | 5 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-05 | 167 | 118 | 5 | 720dc5855c856b478b5ca90156b30bfcc5518d60 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-05 | 167 | 118 | 5 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 168 | 118 | 5 | e156297a7515e785a9e79a9676700bd3a9d92b98 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 168 | 118 | 5 | 32e0bc0873baa13027241063283ef26d2aab56f5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.25e-05 | 171 | 118 | 5 | b520d4d5620cac08315e4cbb7e796c5e9e233060 | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 172 | 118 | 5 | 36fe66a8c0aecee7a19269be23210c0ed7abb155 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-04 | 174 | 118 | 5 | eaaf17a06efc09ed4752b449827b1f0f424d3dad | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-04 | 174 | 118 | 5 | 36080fa12497faa752ff07ae52cd3864053eafef | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 118 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 175 | 118 | 5 | fe27c3279f660b5be4193005394b77163c599d32 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.06e-04 | 176 | 118 | 5 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| Computational | Genes in the cancer module 27. | 1.08e-04 | 355 | 58 | 9 | MODULE_27 | |
| Computational | Genes in the cancer module 146. | 2.14e-04 | 102 | 58 | 5 | MODULE_146 | |
| Drug | AC1L1I54 | 5.10e-08 | 41 | 113 | 6 | CID000004426 | |
| Drug | Lopac-S-1316 | 1.58e-06 | 40 | 113 | 5 | CID003086457 | |
| Drug | 1,3-dipropylxanthine | 1.84e-06 | 74 | 113 | 6 | CID000169317 | |
| Drug | Peptavlon | 2.51e-06 | 78 | 113 | 6 | CID000021701 | |
| Drug | trimetoquinol | 5.66e-06 | 24 | 113 | 4 | CID000005581 | |
| Drug | AC1L1EV8 | 6.55e-06 | 8 | 113 | 3 | CID000002964 | |
| Drug | tiotidine | 6.71e-06 | 25 | 113 | 4 | CID000050287 | |
| Drug | GTP[S] | DOCK1 ADCY4 NPY2R CFTR RXFP3 SSTR2 SSTR4 ADCY1 ADCY6 MGP P2RY1 PKD2 HRH1 | 7.62e-06 | 591 | 113 | 13 | CID000001764 |
| Drug | 14,15-dihydroforskolin | 9.78e-06 | 9 | 113 | 3 | CID000194193 | |
| Drug | etorphine | 1.11e-05 | 59 | 113 | 5 | CID000026721 | |
| Drug | Vasotocin | 1.11e-05 | 59 | 113 | 5 | CID000024774 | |
| Drug | tolazoline | 1.24e-05 | 29 | 113 | 4 | CID000005504 | |
| Drug | 2',5'-dd3'-FSBA | 1.39e-05 | 10 | 113 | 3 | CID003081206 | |
| Drug | NC-5Z | 1.39e-05 | 10 | 113 | 3 | CID003035914 | |
| Drug | iodide | ADCY4 NPY2R CFTR XK SSTR2 SSTR4 ADCY1 ADCY6 CHRNA4 CD8A SCARB1 CXCR2 | 1.41e-05 | 534 | 113 | 12 | CID000024841 |
| Drug | oxotremorine | 1.66e-05 | 108 | 113 | 6 | CID000004630 | |
| Drug | AC1L40QM | 1.91e-05 | 11 | 113 | 3 | CID000099213 | |
| Drug | B-Mlvp | 1.91e-05 | 11 | 113 | 3 | CID000195648 | |
| Drug | AC1NY9KD | 1.91e-05 | 11 | 113 | 3 | CID005771741 | |
| Drug | benzilate | 1.93e-05 | 66 | 113 | 5 | CID000201538 | |
| Drug | metiamide | 2.11e-05 | 33 | 113 | 4 | CID001548992 | |
| Drug | Depixol | 2.11e-05 | 33 | 113 | 4 | CID000017011 | |
| Drug | AC1NSKJI | 2.24e-05 | 68 | 113 | 5 | CID005311391 | |
| Drug | AC1L1DSZ | 3.00e-05 | 36 | 113 | 4 | CID000002494 | |
| Drug | i-Pr | 3.16e-05 | 73 | 113 | 5 | CID000448400 | |
| Drug | FCE 23884 | 3.28e-05 | 13 | 113 | 3 | CID000065898 | |
| Drug | AC1L1BJN | 3.28e-05 | 13 | 113 | 3 | CID000001467 | |
| Drug | sclareol glycol | 3.28e-05 | 13 | 113 | 3 | CID000091915 | |
| Drug | nantradol hydrochloride | 3.28e-05 | 13 | 113 | 3 | CID000047652 | |
| Drug | Ts-I | 3.61e-05 | 75 | 113 | 5 | CID000445278 | |
| Drug | AC1L1B9H | 4.36e-05 | 78 | 113 | 5 | CID000001341 | |
| Drug | dimaprit | 4.58e-05 | 40 | 113 | 4 | CID000003077 | |
| Drug | SKF 75670 | 5.19e-05 | 15 | 113 | 3 | CID000173870 | |
| Drug | BMY 42393 | 5.19e-05 | 15 | 113 | 3 | CID000131961 | |
| Drug | AC1L2AAS | 5.19e-05 | 15 | 113 | 3 | CID000068714 | |
| Drug | CGP 12177 | 5.57e-05 | 42 | 113 | 4 | CID000002687 | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 2782_DN | |
| Drug | atropine sulfate | 5.94e-05 | 347 | 113 | 9 | CID000003661 | |
| Drug | AC1L9NAZ | 6.00e-05 | 198 | 113 | 7 | CID000449606 | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 2652_UP | |
| Drug | AC1L1DI0 | 6.36e-05 | 16 | 113 | 3 | CID000002357 | |
| Drug | EN-1530 | 7.56e-05 | 278 | 113 | 8 | CID000004425 | |
| Drug | San 21009 | 7.69e-05 | 17 | 113 | 3 | CID000152662 | |
| Drug | U754 | 7.69e-05 | 17 | 113 | 3 | CID000062824 | |
| Drug | fentanyl isothiocyanate | 7.69e-05 | 17 | 113 | 3 | CID000084008 | |
| Drug | tacrine | 8.36e-05 | 144 | 113 | 6 | CID000001935 | |
| Drug | muscarine | 8.36e-05 | 144 | 113 | 6 | CID000009308 | |
| Drug | procaterol | 9.46e-05 | 48 | 113 | 4 | CID000004916 | |
| Drug | AC1L9NBR | 9.61e-05 | 92 | 113 | 5 | CID000449625 | |
| Drug | pirenzepine | 1.01e-04 | 93 | 113 | 5 | CID000004848 | |
| Drug | 1,3-DCG | 1.06e-04 | 94 | 113 | 5 | CID000150911 | |
| Drug | fluphenazine | 1.06e-04 | 94 | 113 | 5 | CID000003372 | |
| Drug | Ro 41-9067 | 1.09e-04 | 19 | 113 | 3 | CID000125800 | |
| Drug | AC1L3XQA | 1.09e-04 | 19 | 113 | 3 | CID000124009 | |
| Drug | trimeprazine | 1.09e-04 | 19 | 113 | 3 | CID000005574 | |
| Drug | SK&F 82958 | 1.09e-04 | 19 | 113 | 3 | ctd:C071262 | |
| Drug | AC1Q7BEJ | 1.11e-04 | 50 | 113 | 4 | CID000001224 | |
| Drug | Gastrin tetrapeptide | 1.11e-04 | 50 | 113 | 4 | CID000005415 | |
| Drug | prochloraz | 1.25e-04 | 155 | 113 | 6 | CID000073665 | |
| Drug | Dvdavp | 1.28e-04 | 20 | 113 | 3 | CID006441676 | |
| Drug | diquafosol | 1.28e-04 | 20 | 113 | 3 | CID000148196 | |
| Drug | YM435 | 1.28e-04 | 20 | 113 | 3 | CID000132119 | |
| Drug | 6-fluoronorepinephrine | 1.48e-04 | 21 | 113 | 3 | CID000001862 | |
| Drug | reproterol | 1.48e-04 | 21 | 113 | 3 | CID000025654 | |
| Drug | Revivon | 1.50e-04 | 54 | 113 | 4 | CID000026644 | |
| Drug | AC1L1E2H | 1.61e-04 | 55 | 113 | 4 | CID000002612 | |
| Drug | GSK835726 | 1.71e-04 | 22 | 113 | 3 | CID005311268 | |
| Drug | methylxanthine | 1.73e-04 | 56 | 113 | 4 | CID000068374 | |
| Drug | Calcium | 1.75e-04 | 493 | 113 | 10 | ctd:D002118 | |
| Drug | ICI 118551 | 1.86e-04 | 57 | 113 | 4 | CID000003682 | |
| Drug | cyanopindolol | 1.86e-04 | 57 | 113 | 4 | CID000155346 | |
| Drug | endrine | 1.87e-04 | 106 | 113 | 5 | CID000003048 | |
| Drug | AC1L1F6H | 1.87e-04 | 106 | 113 | 5 | CID000003104 | |
| Drug | beta-CNA | 1.96e-04 | 23 | 113 | 3 | CID005486190 | |
| Drug | Scpb | 1.96e-04 | 23 | 113 | 3 | CID000123843 | |
| Drug | Prostaglandin D2-d4 | 1.98e-04 | 240 | 113 | 7 | CID000004956 | |
| Drug | trequinsin | 1.99e-04 | 58 | 113 | 4 | CID000005537 | |
| Drug | NAIN | 2.23e-04 | 24 | 113 | 3 | CID000195228 | |
| Drug | TL-99 | 2.23e-04 | 24 | 113 | 3 | CID000122132 | |
| Drug | DEPX | 2.23e-04 | 24 | 113 | 3 | CID000001328 | |
| Drug | AC1L8VEV | 2.23e-04 | 24 | 113 | 3 | CID000433433 | |
| Drug | PNU-107859 | 2.35e-04 | 174 | 113 | 6 | CID004369084 | |
| Drug | otenzepad | 2.41e-04 | 61 | 113 | 4 | CID000107867 | |
| Drug | iodobolpyramine | 2.42e-04 | 5 | 113 | 2 | CID000127808 | |
| Drug | UTP-NA | 2.50e-04 | 420 | 113 | 9 | CID000001181 | |
| Drug | 1iiq | 2.52e-04 | 113 | 113 | 5 | CID000446293 | |
| Drug | AC1L9NB5 | 2.53e-04 | 25 | 113 | 3 | CID000449609 | |
| Drug | PD 81,723 | 2.53e-04 | 25 | 113 | 3 | CID000122028 | |
| Drug | octimibate | 2.53e-04 | 25 | 113 | 3 | CID000065676 | |
| Drug | manganese-ATP | 2.53e-04 | 25 | 113 | 3 | CID000124341 | |
| Drug | N-n-propylnorapomorphine | 2.53e-04 | 25 | 113 | 3 | CID000030137 | |
| Drug | 8-phenyltheophylline | 2.57e-04 | 62 | 113 | 4 | CID000001922 | |
| Drug | AC1NE3N8 | 2.66e-04 | 178 | 113 | 6 | CID004636050 | |
| Drug | CAS 66104-23-2 | 2.73e-04 | 63 | 113 | 4 | CID000004745 | |
| Drug | sodium cromoglycate | 2.73e-04 | 63 | 113 | 4 | CID000002881 | |
| Drug | phenoxybenzamine | 2.74e-04 | 115 | 113 | 5 | CID000004768 | |
| Drug | metaproterenol | 2.85e-04 | 26 | 113 | 3 | CID000004086 | |
| Drug | 7B-forskolin | 2.85e-04 | 26 | 113 | 3 | CID000130638 | |
| Drug | AAGTP | 2.91e-04 | 64 | 113 | 4 | CID000656407 | |
| Drug | xanthine amine congener | 2.91e-04 | 64 | 113 | 4 | CID000005697 | |
| Disease | polycystic kidney disease (is_implicated_in) | 7.63e-05 | 4 | 106 | 2 | DOID:0080322 (is_implicated_in) | |
| Disease | renal system measurement, uric acid measurement | 1.90e-04 | 6 | 106 | 2 | EFO_0004742, EFO_0004761 | |
| Disease | Polycystic Kidney Diseases | 1.90e-04 | 6 | 106 | 2 | C0022680 | |
| Disease | Rhinitis | 3.53e-04 | 8 | 106 | 2 | C0035455 | |
| Disease | Peritoneal Neoplasms | 5.65e-04 | 10 | 106 | 2 | C0031149 | |
| Disease | Carcinomatosis of peritoneal cavity | 5.65e-04 | 10 | 106 | 2 | C0346990 | |
| Disease | Kidney Failure, Chronic | 6.93e-04 | 48 | 106 | 3 | C0022661 | |
| Disease | Drug habituation | 8.01e-04 | 115 | 106 | 4 | C0013170 | |
| Disease | Drug abuse | 8.01e-04 | 115 | 106 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 8.01e-04 | 115 | 106 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 8.01e-04 | 115 | 106 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 8.01e-04 | 115 | 106 | 4 | C0013222 | |
| Disease | Drug Dependence | 8.01e-04 | 115 | 106 | 4 | C1510472 | |
| Disease | Substance Dependence | 8.01e-04 | 115 | 106 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 8.01e-04 | 115 | 106 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 8.01e-04 | 115 | 106 | 4 | C0029231 | |
| Disease | Substance abuse problem | 8.27e-04 | 116 | 106 | 4 | C0740858 | |
| Disease | response to cisplatin, platinum measurement | 9.26e-04 | 53 | 106 | 3 | EFO_0010154, GO_0072718 | |
| Disease | Withdrawal Symptoms | 1.20e-03 | 58 | 106 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.20e-03 | 58 | 106 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.20e-03 | 58 | 106 | 3 | C0038587 | |
| Disease | Vascular Diseases | 1.68e-03 | 17 | 106 | 2 | C0042373 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 2.10e-03 | 19 | 106 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 2.56e-03 | 261 | 106 | 5 | C0004352 | |
| Disease | longitudinal BMI measurement | 3.25e-03 | 82 | 106 | 3 | EFO_0005937 | |
| Disease | tobacco smoke exposure measurement | 3.35e-03 | 24 | 106 | 2 | EFO_0009115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YTINLIIPCLLISCL | 246 | P43681 | |
| TLVGCILSVVLVLIY | 376 | Q86WK6 | |
| IYLGIGLCLLFIVRT | 121 | P13569 | |
| GVLIVLVLCSAFLLL | 51 | Q9HC47 | |
| YASIFLLLLITVLIC | 701 | O43306 | |
| LLLLITVLICAVYSC | 706 | O43306 | |
| LLALSFNILLLVVIC | 61 | P07307 | |
| PVVYTTAIILLLCLL | 761 | Q8IWK6 | |
| LVGSLLVAALVCFLL | 246 | Q3KPI0 | |
| ARILCALYVVVSILL | 391 | Q8TAX9 | |
| VGLTISLLCLFLAIL | 196 | Q86SQ3 | |
| QYPLLLLLLGIVLCA | 26 | Q8NFM4 | |
| GTCGVLLLSLVITLY | 191 | P01732 | |
| AILAILLGIALLFCI | 696 | Q02487 | |
| LLGIALLFCILFTLV | 701 | Q02487 | |
| IVFRVELCLFLGLLL | 181 | Q9BV10 | |
| LVLTLLLYTVLRCSA | 711 | Q9Y5H5 | |
| VVLILAYCSIILLGV | 51 | P49146 | |
| CIRLLILSYIAGILH | 141 | A6NDH6 | |
| ILGVLLASGLIYCLR | 626 | Q92932 | |
| IRVNIIYGLCAISIL | 191 | Q8NGJ3 | |
| VLILGCYGLIVRALI | 231 | P47900 | |
| GIVAAAALCILILLY | 401 | P58400 | |
| CLVLVSYLHILVAIL | 211 | Q8NGT7 | |
| CLVLVSYLRILAAIL | 211 | Q96R47 | |
| LIIFLALGATECLLL | 101 | O76000 | |
| LILSSYGLILAAVLL | 211 | Q8NG77 | |
| LIYLSIVCVLGISAI | 236 | Q96A54 | |
| ACILVVLLAIFLYLL | 556 | Q9NQZ7 | |
| AVALLILILLIVCFI | 1176 | Q92823 | |
| LIGCLVAIIFILLAI | 401 | Q16832 | |
| CRGILVVYNLGLTLL | 61 | Q9NYP7 | |
| LKYTLGFVVICALLL | 141 | Q9NUN5 | |
| VPLLLLLCVLGLTYA | 631 | P51511 | |
| ILIGVSVVFLFCLLL | 166 | Q6GTX8 | |
| LVCVLVALAIVYLIA | 1166 | P15941 | |
| VLRTYLELVLCVLVS | 181 | Q7Z6M2 | |
| CLFYIIILVLALLET | 356 | Q63HM2 | |
| LLLVSYVVILCSLRT | 211 | A6NHA9 | |
| PCILLSYILIIRSVL | 226 | Q8NH61 | |
| LSLVCFLLLLVSYGV | 206 | Q8NH42 | |
| CFLLLLISYTVILLA | 211 | Q8NGD5 | |
| LSCFIILLISYSLIL | 211 | Q8NGC6 | |
| GTVRLLLILSGCLVY | 26 | O14524 | |
| ILLYILCALLTITVA | 41 | Q5KU26 | |
| LCALLTITVAILGYK | 46 | Q5KU26 | |
| VVIIYALVFLLSLLG | 51 | P25025 | |
| ALINILLVTTGYIIC | 221 | O14626 | |
| GIVAAAALCILILLY | 1641 | Q9P2S2 | |
| EIQCLGLSLIGYLIT | 601 | Q5S007 | |
| TIVGYILLAITLIIC | 336 | O60337 | |
| ACVSLSLLSVVLLYL | 426 | Q9H3U5 | |
| GIVAAAALCILILLY | 1406 | Q9ULB1 | |
| LLCATITILYLLALI | 26 | Q9H205 | |
| VLFALVLLCYLLTLT | 26 | Q8NGU4 | |
| LAFICLSYLLILATI | 211 | Q8NGT2 | |
| VSILTLCLIALGRYL | 106 | Q9NQS5 | |
| LCLVLVSYSRILAAI | 211 | Q96R48 | |
| LVLTLLLYTALRCSV | 711 | Q9Y5I3 | |
| LLLCIAYTVVLIVGL | 36 | Q99463 | |
| IVAAAALCILILLYA | 596 | P58401 | |
| AVCGSILFLLIVLLL | 386 | P11117 | |
| TLILAALFGLVYLLI | 616 | Q08828 | |
| GLLTIQKLYCLIEIV | 831 | Q14185 | |
| ALAVLACLLFLLIVG | 306 | P15813 | |
| ALGLVAVLCLVIIYV | 116 | Q8N8J7 | |
| ALIAILACIFVLLVL | 621 | Q9HBT6 | |
| ITLGSILLLGLLVYL | 716 | Q6ZTQ4 | |
| LLVLISVDRCISVLY | 131 | Q8NGA4 | |
| LLIACAFTLSLVYLI | 36 | Q16850 | |
| CALVLLLVILLSYVG | 56 | Q9Y5Q5 | |
| LSTFCLLLLYLIGAV | 6 | Q9UBS4 | |
| VLTCLVLALLAVYLS | 106 | Q8N112 | |
| YLICVSFLLTILLEL | 6 | Q6UXX5 | |
| LLLLLLLQPVTCAYT | 21 | Q9H4A9 | |
| ALAGLVLIVLIAYLV | 391 | P11279 | |
| LVVAFGLLVLYILLA | 206 | Q8NBI2 | |
| TICLVTVGLNLLVLY | 36 | P35367 | |
| ICILLNLVELIYLVS | 196 | O95377 | |
| ILAFCAGVLLTLLLI | 41 | Q8NEQ5 | |
| LATGIVLVLLLLCLY | 716 | Q12770 | |
| LCVLILLILVVLFAA | 621 | Q9ULB4 | |
| LLAILAALAVVTLCY | 6 | P08493 | |
| TCVLILLFSLALIIL | 296 | Q8TEY5 | |
| LDLGLLYLVLILPSC | 646 | Q86YC3 | |
| LYLVLILPSCLTLLV | 651 | Q86YC3 | |
| LIYLAVLVGNLLIIA | 31 | A6ND48 | |
| LLCLIILIFFLASVG | 26 | Q8N349 | |
| AYTLALLGNCTLLLI | 36 | Q8NGK3 | |
| IVCILVLAVLGAVLY | 566 | P43121 | |
| VLLLAVLCKVYLGLF | 11 | Q6NUM9 | |
| GIIILCYLLLVRFIA | 281 | Q9NSD7 | |
| QYVLLSILLCLLASG | 86 | Q9BVX2 | |
| LVQGLCALLLGISIY | 536 | O60763 | |
| ARVLCLIVLPLALYT | 281 | Q9UKY4 | |
| LIYACLLLFSVLLAL | 16 | Q8NFB2 | |
| VFVLLLVLSLAIGLY | 31 | Q9Y289 | |
| LFSGCFLVVLLAILL | 566 | Q9Y227 | |
| IYAGVCISVLVLLAL | 296 | Q96D42 | |
| LILGLLVVFILSVCF | 621 | Q9H156 | |
| LLPVLAIGLCYLLIV | 221 | P31391 | |
| LLLLSVALVVLFIGC | 61 | A0A1B0GUA5 | |
| VGLLLLLVSILGYSL | 16 | A0A1B0GVV1 | |
| YVLLALGCVLLLVPV | 446 | Q8WTV0 | |
| TSVCGLVLLFLLLLY | 71 | Q6ZUB1 | |
| LYLTILLTVLVFLLC | 221 | Q96LB1 | |
| LIVLISYGLILLAIL | 251 | Q8NGG2 | |
| IGLCGNTLVIYVILR | 56 | P30874 | |
| VAFLACYGLVLLVLL | 131 | O75352 | |
| YVGLSVSLLCLLLAA | 361 | Q9BY15 | |
| IALLVALFGLLVYLA | 86 | P56747 | |
| LLAYTLVSVCVLLLR | 416 | Q8TBB6 | |
| VRLALCLTGLVLSLY | 11 | Q9BQB6 | |
| LYVLAIAALGGLCLI | 676 | Q9NTN9 | |
| CFVAILIGLCLTLLL | 391 | P49810 | |
| LGYLARINLLVAICL | 36 | Q9H0V1 | |
| LRELVTYLLFLIVLC | 221 | Q13563 | |
| YVGLIAVAVCLVLLL | 306 | Q6ZN44 | |
| AVLLLVSCLILIFVI | 201 | Q0D2K0 | |
| TVILLIFLCLEGLLF | 216 | Q9NXF8 | |
| IVLALIGAIFLLVLY | 361 | Q13641 | |
| IGITALLFLCLALII | 556 | Q96LC7 | |
| LGYLGLLLLDVIICL | 211 | Q9C0H2 | |
| LVLQLLIGYCTAILF | 351 | P51811 | |
| ALLGVLLLVLVATYV | 186 | Q8WTX9 |